Clinical trial
DHPLC Determination of TPMT Polymorphisms.
NCT00402090 · National Institute of Cancerología, Other · Unknown status
Key facts
| NCT number | NCT00402090 |
|---|---|
| Title | DHPLC Determination of TPMT Polymorphisms. |
| Official title | Prevention of Thiopurines Related Toxicity Through the Determination by DHPLC TPMT Polymorphisms in Patients With ALL. |
| Lead sponsor | National Institute of Cancerología, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Acute Lymphoblastic Leukemia |
| Enrollment | 160 |
| Start date | Apr 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Nov 22, 2006 |
| Last update posted | Nov 22, 2006 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: